Matthew Kunicki

Matthew Kunicki is the founder and CEO of Interro IQ, research services company helping to build AI-driven flow cytometry for biomarker discovery. He completed his education at California State University, Long Beach, with a Bachelor’s in Biochemistry and certifications in Philosophy and English Writing and received the CSUPERB Presidents’ Commission Award for work on metalloproteases. He later pursued an associate research role at Stanford University’s Department of Stem Cell & Regenerative Medicine, helping characterize regulatory T-cell dysfunction in autoimmunity and immune deficiency by mass cytometry. At Pfizer, he supported flow cytometry applications across multiple research arms, led enterprise SDMS solutions for flow cytometry analysis, and evaluated external technology innovations for pre-clinical and clinical research.